Annual Working Capital
$110.54 M
-$107.83 M-49.38%
31 December 2023
Summary:
Inovio Pharmaceuticals annual working capital is currently $110.54 million, with the most recent change of -$107.83 million (-49.38%) on 31 December 2023. During the last 3 years, it has fallen by -$318.92 million (-74.26%). INO annual working capital is now -74.26% below its all-time high of $429.46 million, reached on 31 December 2020.INO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$67.79 M
-$23.38 M-25.64%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly working capital is currently $67.79 million, with the most recent change of -$23.38 million (-25.64%) on 30 September 2024. Over the past year, it has dropped by -$63.27 million (-48.28%). INO quarterly working capital is now -87.61% below its all-time high of $546.90 million, reached on 31 March 2021.INO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.4% | -48.3% |
| 3 y3 years | -74.3% | -84.5% |
| 5 y5 years | +110.5% | -14.5% |
INO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.3% | at low | -84.5% | at low |
| 5 y | 5 years | -74.3% | +110.5% | -87.6% | +9.0% |
| alltime | all time | -74.3% | >+9999.0% | -87.6% | +2658.8% |
Inovio Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $67.79 M(-25.6%) |
| June 2024 | - | $91.16 M(+3.3%) |
| Mar 2024 | - | $88.28 M(-20.1%) |
| Dec 2023 | $110.54 M(-49.4%) | $110.54 M(-15.7%) |
| Sept 2023 | - | $131.06 M(-13.4%) |
| June 2023 | - | $151.35 M(-15.3%) |
| Mar 2023 | - | $178.75 M(-18.1%) |
| Dec 2022 | $218.37 M(-42.9%) | $218.37 M(-14.5%) |
| Sept 2022 | - | $255.29 M(-10.5%) |
| June 2022 | - | $285.12 M(-16.3%) |
| Mar 2022 | - | $340.55 M(-11.0%) |
| Dec 2021 | $382.70 M(-10.9%) | $382.70 M(-12.2%) |
| Sept 2021 | - | $436.02 M(-11.1%) |
| June 2021 | - | $490.68 M(-10.3%) |
| Mar 2021 | - | $546.90 M(+27.3%) |
| Dec 2020 | $429.46 M(+590.3%) | $429.46 M(+27.9%) |
| Sept 2020 | - | $335.80 M(-2.4%) |
| June 2020 | - | $344.08 M(+41.5%) |
| Mar 2020 | - | $243.25 M(+291.0%) |
| Dec 2019 | $62.21 M(+18.5%) | $62.21 M(-21.5%) |
| Sept 2019 | - | $79.27 M(-8.3%) |
| June 2019 | - | $86.43 M(-19.6%) |
| Mar 2019 | - | $107.49 M(+104.7%) |
| Dec 2018 | $52.52 M(-49.0%) | $52.52 M(-20.0%) |
| Sept 2018 | - | $65.60 M(-10.7%) |
| June 2018 | - | $73.43 M(+1.3%) |
| Mar 2018 | - | $72.46 M(-29.6%) |
| Dec 2017 | $102.96 M(+27.5%) | $102.96 M(-15.1%) |
| Sept 2017 | - | $121.22 M(+52.5%) |
| June 2017 | - | $79.50 M(+19.0%) |
| Mar 2017 | - | $66.78 M(-17.3%) |
| Dec 2016 | $80.77 M(-42.5%) | $80.77 M(-18.3%) |
| Sept 2016 | - | $98.86 M(-12.1%) |
| June 2016 | - | $112.47 M(-11.6%) |
| Mar 2016 | - | $127.20 M(-9.4%) |
| Dec 2015 | $140.38 M(+65.4%) | $140.38 M(-15.3%) |
| Sept 2015 | - | $165.80 M(+12.3%) |
| June 2015 | - | $147.62 M(+86.5%) |
| Mar 2015 | - | $79.17 M(-6.7%) |
| Dec 2014 | $84.86 M(+185.6%) | $84.86 M(-11.3%) |
| Sept 2014 | - | $95.71 M(-5.6%) |
| June 2014 | - | $101.34 M(-4.4%) |
| Mar 2014 | - | $106.04 M(+256.8%) |
| Dec 2013 | $29.72 M(+291.5%) | $29.72 M(-20.6%) |
| Sept 2013 | - | $37.42 M(+478.7%) |
| June 2013 | - | $6.47 M(-54.9%) |
| Mar 2013 | - | $14.34 M(+88.9%) |
| Dec 2012 | $7.59 M(-63.6%) | $7.59 M(+34.2%) |
| Sept 2012 | - | $5.66 M(-49.0%) |
| June 2012 | - | $11.09 M(-20.4%) |
| Mar 2012 | - | $13.92 M(-33.3%) |
| Dec 2011 | $20.86 M | $20.86 M(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $23.03 M(-19.7%) |
| June 2011 | - | $28.67 M(+1.3%) |
| Mar 2011 | - | $28.30 M(+72.1%) |
| Dec 2010 | $16.44 M(-34.8%) | $16.44 M(-13.7%) |
| Sept 2010 | - | $19.05 M(-12.0%) |
| June 2010 | - | $21.64 M(-14.9%) |
| Mar 2010 | - | $25.43 M(+0.9%) |
| Dec 2009 | $25.22 M(+4450.1%) | $25.22 M(-7.2%) |
| Sept 2009 | - | $27.18 M(+543.6%) |
| June 2009 | - | $4.22 M(-259.5%) |
| Mar 2009 | - | -$2.65 M(-578.0%) |
| Dec 2008 | $554.20 K(-97.8%) | $554.20 K(-83.9%) |
| Sept 2008 | - | $3.44 M(-39.4%) |
| June 2008 | - | $5.68 M(-40.3%) |
| Mar 2008 | - | $9.51 M(-62.9%) |
| Dec 2007 | $25.65 M(+45.6%) | $25.65 M(-3.3%) |
| Sept 2007 | - | $26.52 M(-11.7%) |
| June 2007 | - | $30.01 M(+69.3%) |
| Mar 2007 | - | $17.72 M(+0.6%) |
| Dec 2006 | $17.61 M(+24.2%) | $17.61 M(+176.6%) |
| Sept 2006 | - | $6.37 M(-31.4%) |
| June 2006 | - | $9.28 M(-23.0%) |
| Mar 2006 | - | $12.05 M(-15.0%) |
| Dec 2005 | $14.19 M(+8.8%) | $14.19 M(+481.4%) |
| Sept 2005 | - | $2.44 M(-55.5%) |
| June 2005 | - | $5.48 M(-28.7%) |
| Mar 2005 | - | $7.68 M(-41.1%) |
| Dec 2004 | $13.04 M(+3.5%) | $13.04 M(-23.0%) |
| Sept 2004 | - | $16.93 M(-17.0%) |
| June 2004 | - | $20.41 M(+64.7%) |
| Mar 2004 | - | $12.39 M(-1.6%) |
| Dec 2003 | $12.59 M(+1111.0%) | $12.59 M(+95.9%) |
| Sept 2003 | - | $6.43 M(+1811.8%) |
| June 2003 | - | $336.30 K(-77.2%) |
| Mar 2003 | - | $1.47 M(+41.7%) |
| Dec 2002 | $1.04 M(-48.1%) | $1.04 M(-59.8%) |
| Sept 2002 | - | $2.59 M(-34.2%) |
| June 2002 | - | $3.93 M(+299.2%) |
| Mar 2002 | - | $984.60 K(-60.3%) |
| Dec 2001 | $2.00 M(-70.3%) | - |
| Sept 2001 | - | $2.48 M(-41.9%) |
| June 2001 | - | $4.27 M(-36.7%) |
| Mar 2001 | - | $6.74 M(+57.3%) |
| Mar 2001 | $6.74 M(-29.1%) | - |
| Dec 2000 | - | $4.28 M(-33.8%) |
| Sept 2000 | - | $6.47 M(-22.4%) |
| June 2000 | - | $8.33 M(-12.4%) |
| Mar 2000 | $9.51 M(+53.4%) | $9.51 M(-12.0%) |
| Dec 1999 | - | $10.80 M(-15.0%) |
| Sept 1999 | - | $12.70 M(-13.6%) |
| June 1999 | - | $14.70 M(+137.1%) |
| Mar 1999 | $6.20 M | $6.20 M(-29.5%) |
| Dec 1998 | - | $8.80 M |
FAQ
- What is Inovio Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual working capital year-on-year change?
- What is Inovio Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly working capital year-on-year change?
What is Inovio Pharmaceuticals annual working capital?
The current annual working capital of INO is $110.54 M
What is the all time high annual working capital for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual working capital is $429.46 M
What is Inovio Pharmaceuticals annual working capital year-on-year change?
Over the past year, INO annual working capital has changed by -$107.83 M (-49.38%)
What is Inovio Pharmaceuticals quarterly working capital?
The current quarterly working capital of INO is $67.79 M
What is the all time high quarterly working capital for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly working capital is $546.90 M
What is Inovio Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, INO quarterly working capital has changed by -$63.27 M (-48.28%)